BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 13, 2016
View Archived Issues
ReNeuron awarded grant to develop stem cell-derived exosomes
Read More
Novartis and Surface Oncology to develop therapeutics targeting the tumor micro-environment
Read More
Healios gains Japanese rights to Athersys's MultiStem
Read More
IBT receives approval to start clinical trials of necrotizing enterocolitis candidate
Read More
Strategic partnership begins between Zymeworks and Kairos Therapeutics
Read More
New NCCN grants support trials of volasertib in hematologic malignancies
Read More
Phase I results indicate potential of TNT-009 in complement-mediated orphan diseases
Read More
Incyte and AstraZeneca to collaborate on INCB-39110/osimertinib combination in NSCLC
Read More
Roche to acquire Tensha Therapeutics
Read More
Juno Therapeutics acquires AbVitro
Read More
Celgene exercises right to license Lycera's ex vivo ROR-gamma agonists
Read More
Bamboo Therapeutics advances development of gene therapy for DMD
Read More
Advinus and Takeda reach third milestone in drug discovery alliance
Read More
Bellicum seeks NIH RAC approval to start clinical trials of TCR therapies
Read More
Abeona receives initial clearance for clinical trials of Sanfilippo syndrome gene therapies
Read More
Tracleer dispersible tablets launched for pediatric use in Japan
Read More
Chugai and Novartis to terminate agreement regarding co-marketing of Femara
Read More
Promising results presented for Altor's novel immunotherapies in bladder cancer
Read More
Estrogen receptor agonist therapy shows favorable phase II results in prostate cancer
Read More
FDA advisory committee recommends approval of Probuphine
Read More
Gilead submits NDA for tenofovir alafenamide for chronic HBV infection
Read More
Elocta is launched in first European countries for the treatment of haemophilia A
Read More
A new national coalition aims to accelerate next generation immunotherapy in cancer
Read More
Sage Therapeutics reports NMDA receptor modulators
Read More
Bristol-Myers Squibb describes CK1 inhibitors
Read More
FDA and EMA accept filings for venetoclax in CLL
Read More
The Medicines Company starts phase II trial of ALN-PCSsc
Read More